Iovance Biotherapeutics Inc. buy Wells Fargo & Company
Start price
08.08.25
/
50%
€1.87
Target price
08.08.26
€12.01
Performance (%)
75.28%
Price
17.04.26
€3.28
Summary
This prediction is currently active. With a performance of 75.28% the BUY prediction by Wells_Fargo___Compan is a big success. This prediction currently runs until 08.08.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Iovance Biotherapeutics Inc. | -6.657% | -6.657% |
| iShares Core DAX® | 0,79 % | 1,97 % |
| iShares Nasdaq 100 | 4,23 % | 4,34 % |
| iShares Nikkei 225® | 3,29 % | 6,99 % |
| iShares S&P 500 | 2,50 % | 2,76 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target lowered by analysts at Wells Fargo & Company from $18.00 to $14.00. They now have an "overweight" rating on the stock.
Ratings data for IOVA provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€11.70
20.02.24
20.02.24
€20.35
20.02.25
20.02.25
-52.82%
21.02.25
21.02.25
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€7.97
30.05.23
30.05.23
€15.85
30.05.24
30.05.24
4.72%
31.05.24
31.05.24